Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Clinical research established that the most commonly effective range is 250-500 mcg (0.25-0.5 mg) administered once daily via subcutaneous injection
28 ClinicalTrials.gov (2020d)
Retatrutide, a GIP, GLP-1 and Glucagon Receptor Agonist, for People With Type 2 Diabetes: A Phase 2 Trial The Lancet Phase 2 trial showed retatrutide achieved 16.9% weight loss with HbA1c improvements of 2.2%, with 82% of participants reaching HbA1c 6.5% after 36 weeks
This can be particularly helpful in managing nausea and promoting more stable blood sugar levels
There are no known direct interactions between Wegovy and common thyroid medicines such as levothyroxine, though dosage adjustments may be needed as weight changes
US$ 28.21
US$ 21.87
US$ 24.09
US$ 20.46
US$ 27.18
US$ 21.75
